Robotic Beating-Heart Bypass (TECAB)
Quick Facts
What Is Robotic Beating-Heart TECAB Surgery?
Traditional coronary artery bypass grafting (CABG) involves a sternotomy, in which the breastbone is divided to give the surgeon access to the heart. Surgeons then reroute blood around blocked coronary arteries using grafts, commonly the internal mammary artery from the chest wall or veins taken from the leg. Totally endoscopic coronary artery bypass (TECAB) performs the same bypass through a few small ports, with a surgeon controlling robotic arms from a console while viewing a magnified three-dimensional image.
In the beating-heart approach, the graft is sewn onto the target artery while the heart continues to beat, using stabilizing devices to hold a small area of the heart still. This avoids cardiopulmonary bypass, the heart-lung machine, which has been associated with inflammatory responses and, in some patients, neurological and kidney complications. Robotic TECAB has been performed for many years at a limited number of specialized centers worldwide, and it demands exceptional technical skill.
Why Does a Dual-Console Robotic System Matter?
Dual-console robotic platforms allow a second surgeon to sit at a separate console, either to assist, swap control with the primary surgeon, or mentor a trainee in real time. For an operation as demanding as beating-heart TECAB, this matters because the learning curve is steep and few surgeons have extensive experience. Shared control may help spread the skill more safely and make it easier to take over during difficult steps.
Reports describing the procedure as a first of its kind using technology made in India also point to a broader trend: domestically developed surgical robots could lower costs and widen access in countries where imported systems have been prohibitively expensive. Such claims should be viewed cautiously until peer-reviewed outcome data are published. Key measures include graft patency, complication rates, recovery time and long-term survival compared with conventional CABG.
Who Might Benefit From Minimally Invasive Bypass Surgery?
Coronary artery disease remains a leading cause of death worldwide according to the World Health Organization. Treatment choices include medication, percutaneous coronary intervention (stenting) and CABG, and the best option depends on the number and location of blockages, diabetes status, heart function and patient preference. Minimally invasive and robotic approaches are generally considered for carefully selected patients, often those with disease in one or a few vessels that can be reached with an internal mammary artery graft.
Potential advantages include less pain, lower risk of breastbone complications and wound infection, and faster return to activity, which can be especially relevant for people with diabetes or obesity. However, these benefits must be weighed against longer operative times in early experience and the need for experienced teams. Patients considering robotic bypass should ask about the center's case volume, conversion rates to open surgery, and graft-patency outcomes.
Frequently Asked Questions
Not necessarily for everyone. Robotic TECAB may reduce wound-related complications and speed recovery in selected patients at experienced centers, but long-term outcomes versus conventional CABG depend on patient selection and surgeon experience.
No. Patients still receive general anesthesia and face surgical risks. 'Beating-heart' refers only to avoiding the heart-lung machine during grafting.
No. It is performed at a limited number of specialized centers because it requires advanced robotic equipment and highly trained teams.
References
- World Health Organization. Cardiovascular diseases (CVDs) fact sheet.
- The Indian Practitioner. India Performs World's First Dual-Console Robotic Beating-Heart TECAB Surgery Using Made-in-India Technology. November 2026.
- American Heart Association/American College of Cardiology. Guideline for Coronary Artery Revascularization. 2021.